Overview

The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effects of subconjunctivally injected bevacizumab in patients with diffuse diabetic macular edema.
Phase:
N/A
Details
Lead Sponsor:
Neon Hospital
Collaborator:
Ondokuz Mayıs University
Treatments:
Bevacizumab